Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Safety and Efficacy of Dental Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis Using Sodium Hyaluronate as a Parallel Control.

NCT04130100 is registered in ClinicalTrials.gov with CAR-T (Shanghai) Biotechnology Co., Ltd. as lead sponsor.

NCT NCT04130100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04130100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Safety and Efficacy of Dental Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis Using Sodium Hyaluronate as a Parallel Control.
Lead sponsor
CAR-T (Shanghai) Biotechnology Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
April 4, 2019
Completion date
December 30, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis